Peroxisome Proliferator Activated Receptor Delta Market
1 Study Coverage
1.1 Peroxisome Proliferator Activated Receptor Delta Product Introduction
1.2 Market by Type
1.2.1 Global Peroxisome Proliferator Activated Receptor Delta Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 MTB-2
1.2.3 HPP-593
1.2.4 CNX-013B2
1.2.5 CS-038
1.2.6 MA-0204
1.2.7 Others
1.3 Market by Application
1.3.1 Global Peroxisome Proliferator Activated Receptor Delta Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Bone Disorders
1.3.3 Colitis
1.3.4 Obesity
1.3.5 Osteoporosis
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Peroxisome Proliferator Activated Receptor Delta Sales Estimates and Forecasts 2017-2028
2.2 Global Peroxisome Proliferator Activated Receptor Delta Revenue Estimates and Forecasts 2017-2028
2.3 Global Peroxisome Proliferator Activated Receptor Delta Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Peroxisome Proliferator Activated Receptor Delta Sales by Region
2.4.1 Global Peroxisome Proliferator Activated Receptor Delta Sales by Region (2017-2022)
2.4.2 Global Sales Peroxisome Proliferator Activated Receptor Delta by Region (2023-2028)
2.5 Global Peroxisome Proliferator Activated Receptor Delta Revenue by Region
2.5.1 Global Peroxisome Proliferator Activated Receptor Delta Revenue by Region (2017-2022)
2.5.2 Global Peroxisome Proliferator Activated Receptor Delta Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Peroxisome Proliferator Activated Receptor Delta Sales by Manufacturers
3.1.1 Global Top Peroxisome Proliferator Activated Receptor Delta Manufacturers by Sales (2017-2022)
3.1.2 Global Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Peroxisome Proliferator Activated Receptor Delta in 2021
3.2 Global Peroxisome Proliferator Activated Receptor Delta Revenue by Manufacturers
3.2.1 Global Peroxisome Proliferator Activated Receptor Delta Revenue by Manufacturers (2017-2022)
3.2.2 Global Peroxisome Proliferator Activated Receptor Delta Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Peroxisome Proliferator Activated Receptor Delta Revenue in 2021
3.3 Global Peroxisome Proliferator Activated Receptor Delta Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Peroxisome Proliferator Activated Receptor Delta Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Peroxisome Proliferator Activated Receptor Delta Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Peroxisome Proliferator Activated Receptor Delta Sales by Type
4.1.1 Global Peroxisome Proliferator Activated Receptor Delta Historical Sales by Type (2017-2022)
4.1.2 Global Peroxisome Proliferator Activated Receptor Delta Forecasted Sales by Type (2023-2028)
4.1.3 Global Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Type (2017-2028)
4.2 Global Peroxisome Proliferator Activated Receptor Delta Revenue by Type
4.2.1 Global Peroxisome Proliferator Activated Receptor Delta Historical Revenue by Type (2017-2022)
4.2.2 Global Peroxisome Proliferator Activated Receptor Delta Forecasted Revenue by Type (2023-2028)
4.2.3 Global Peroxisome Proliferator Activated Receptor Delta Revenue Market Share by Type (2017-2028)
4.3 Global Peroxisome Proliferator Activated Receptor Delta Price by Type
4.3.1 Global Peroxisome Proliferator Activated Receptor Delta Price by Type (2017-2022)
4.3.2 Global Peroxisome Proliferator Activated Receptor Delta Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Peroxisome Proliferator Activated Receptor Delta Sales by Application
5.1.1 Global Peroxisome Proliferator Activated Receptor Delta Historical Sales by Application (2017-2022)
5.1.2 Global Peroxisome Proliferator Activated Receptor Delta Forecasted Sales by Application (2023-2028)
5.1.3 Global Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Application (2017-2028)
5.2 Global Peroxisome Proliferator Activated Receptor Delta Revenue by Application
5.2.1 Global Peroxisome Proliferator Activated Receptor Delta Historical Revenue by Application (2017-2022)
5.2.2 Global Peroxisome Proliferator Activated Receptor Delta Forecasted Revenue by Application (2023-2028)
5.2.3 Global Peroxisome Proliferator Activated Receptor Delta Revenue Market Share by Application (2017-2028)
5.3 Global Peroxisome Proliferator Activated Receptor Delta Price by Application
5.3.1 Global Peroxisome Proliferator Activated Receptor Delta Price by Application (2017-2022)
5.3.2 Global Peroxisome Proliferator Activated Receptor Delta Price Forecast by Application (2023-2028)
6 North America
6.1 North America Peroxisome Proliferator Activated Receptor Delta Market Size by Type
6.1.1 North America Peroxisome Proliferator Activated Receptor Delta Sales by Type (2017-2028)
6.1.2 North America Peroxisome Proliferator Activated Receptor Delta Revenue by Type (2017-2028)
6.2 North America Peroxisome Proliferator Activated Receptor Delta Market Size by Application
6.2.1 North America Peroxisome Proliferator Activated Receptor Delta Sales by Application (2017-2028)
6.2.2 North America Peroxisome Proliferator Activated Receptor Delta Revenue by Application (2017-2028)
6.3 North America Peroxisome Proliferator Activated Receptor Delta Market Size by Country
6.3.1 North America Peroxisome Proliferator Activated Receptor Delta Sales by Country (2017-2028)
6.3.2 North America Peroxisome Proliferator Activated Receptor Delta Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Peroxisome Proliferator Activated Receptor Delta Market Size by Type
7.1.1 Europe Peroxisome Proliferator Activated Receptor Delta Sales by Type (2017-2028)
7.1.2 Europe Peroxisome Proliferator Activated Receptor Delta Revenue by Type (2017-2028)
7.2 Europe Peroxisome Proliferator Activated Receptor Delta Market Size by Application
7.2.1 Europe Peroxisome Proliferator Activated Receptor Delta Sales by Application (2017-2028)
7.2.2 Europe Peroxisome Proliferator Activated Receptor Delta Revenue by Application (2017-2028)
7.3 Europe Peroxisome Proliferator Activated Receptor Delta Market Size by Country
7.3.1 Europe Peroxisome Proliferator Activated Receptor Delta Sales by Country (2017-2028)
7.3.2 Europe Peroxisome Proliferator Activated Receptor Delta Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Peroxisome Proliferator Activated Receptor Delta Market Size by Type
8.1.1 Asia Pacific Peroxisome Proliferator Activated Receptor Delta Sales by Type (2017-2028)
8.1.2 Asia Pacific Peroxisome Proliferator Activated Receptor Delta Revenue by Type (2017-2028)
8.2 Asia Pacific Peroxisome Proliferator Activated Receptor Delta Market Size by Application
8.2.1 Asia Pacific Peroxisome Proliferator Activated Receptor Delta Sales by Application (2017-2028)
8.2.2 Asia Pacific Peroxisome Proliferator Activated Receptor Delta Revenue by Application (2017-2028)
8.3 Asia Pacific Peroxisome Proliferator Activated Receptor Delta Market Size by Region
8.3.1 Asia Pacific Peroxisome Proliferator Activated Receptor Delta Sales by Region (2017-2028)
8.3.2 Asia Pacific Peroxisome Proliferator Activated Receptor Delta Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Peroxisome Proliferator Activated Receptor Delta Market Size by Type
9.1.1 Latin America Peroxisome Proliferator Activated Receptor Delta Sales by Type (2017-2028)
9.1.2 Latin America Peroxisome Proliferator Activated Receptor Delta Revenue by Type (2017-2028)
9.2 Latin America Peroxisome Proliferator Activated Receptor Delta Market Size by Application
9.2.1 Latin America Peroxisome Proliferator Activated Receptor Delta Sales by Application (2017-2028)
9.2.2 Latin America Peroxisome Proliferator Activated Receptor Delta Revenue by Application (2017-2028)
9.3 Latin America Peroxisome Proliferator Activated Receptor Delta Market Size by Country
9.3.1 Latin America Peroxisome Proliferator Activated Receptor Delta Sales by Country (2017-2028)
9.3.2 Latin America Peroxisome Proliferator Activated Receptor Delta Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Peroxisome Proliferator Activated Receptor Delta Market Size by Type
10.1.1 Middle East and Africa Peroxisome Proliferator Activated Receptor Delta Sales by Type (2017-2028)
10.1.2 Middle East and Africa Peroxisome Proliferator Activated Receptor Delta Revenue by Type (2017-2028)
10.2 Middle East and Africa Peroxisome Proliferator Activated Receptor Delta Market Size by Application
10.2.1 Middle East and Africa Peroxisome Proliferator Activated Receptor Delta Sales by Application (2017-2028)
10.2.2 Middle East and Africa Peroxisome Proliferator Activated Receptor Delta Revenue by Application (2017-2028)
10.3 Middle East and Africa Peroxisome Proliferator Activated Receptor Delta Market Size by Country
10.3.1 Middle East and Africa Peroxisome Proliferator Activated Receptor Delta Sales by Country (2017-2028)
10.3.2 Middle East and Africa Peroxisome Proliferator Activated Receptor Delta Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Chipscreen Biosciences Ltd
11.1.1 Chipscreen Biosciences Ltd Corporation Information
11.1.2 Chipscreen Biosciences Ltd Overview
11.1.3 Chipscreen Biosciences Ltd Peroxisome Proliferator Activated Receptor Delta Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Chipscreen Biosciences Ltd Peroxisome Proliferator Activated Receptor Delta Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Chipscreen Biosciences Ltd Recent Developments
11.2 Connexios Life Sciences Pvt Ltd
11.2.1 Connexios Life Sciences Pvt Ltd Corporation Information
11.2.2 Connexios Life Sciences Pvt Ltd Overview
11.2.3 Connexios Life Sciences Pvt Ltd Peroxisome Proliferator Activated Receptor Delta Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Connexios Life Sciences Pvt Ltd Peroxisome Proliferator Activated Receptor Delta Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Connexios Life Sciences Pvt Ltd Recent Developments
11.3 CymaBay Therapeutics Inc
11.3.1 CymaBay Therapeutics Inc Corporation Information
11.3.2 CymaBay Therapeutics Inc Overview
11.3.3 CymaBay Therapeutics Inc Peroxisome Proliferator Activated Receptor Delta Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 CymaBay Therapeutics Inc Peroxisome Proliferator Activated Receptor Delta Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 CymaBay Therapeutics Inc Recent Developments
11.4 Genfit SA
11.4.1 Genfit SA Corporation Information
11.4.2 Genfit SA Overview
11.4.3 Genfit SA Peroxisome Proliferator Activated Receptor Delta Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Genfit SA Peroxisome Proliferator Activated Receptor Delta Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Genfit SA Recent Developments
11.5 Inventiva
11.5.1 Inventiva Corporation Information
11.5.2 Inventiva Overview
11.5.3 Inventiva Peroxisome Proliferator Activated Receptor Delta Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Inventiva Peroxisome Proliferator Activated Receptor Delta Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Inventiva Recent Developments
11.6 Mitobridge Inc
11.6.1 Mitobridge Inc Corporation Information
11.6.2 Mitobridge Inc Overview
11.6.3 Mitobridge Inc Peroxisome Proliferator Activated Receptor Delta Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Mitobridge Inc Peroxisome Proliferator Activated Receptor Delta Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Mitobridge Inc Recent Developments
11.7 Nippon Chemiphar Co Ltd
11.7.1 Nippon Chemiphar Co Ltd Corporation Information
11.7.2 Nippon Chemiphar Co Ltd Overview
11.7.3 Nippon Chemiphar Co Ltd Peroxisome Proliferator Activated Receptor Delta Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Nippon Chemiphar Co Ltd Peroxisome Proliferator Activated Receptor Delta Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Nippon Chemiphar Co Ltd Recent Developments
11.8 Senju Pharmaceutical Co Ltd
11.8.1 Senju Pharmaceutical Co Ltd Corporation Information
11.8.2 Senju Pharmaceutical Co Ltd Overview
11.8.3 Senju Pharmaceutical Co Ltd Peroxisome Proliferator Activated Receptor Delta Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Senju Pharmaceutical Co Ltd Peroxisome Proliferator Activated Receptor Delta Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Senju Pharmaceutical Co Ltd Recent Developments
11.9 T3D Therapeutics Inc
11.9.1 T3D Therapeutics Inc Corporation Information
11.9.2 T3D Therapeutics Inc Overview
11.9.3 T3D Therapeutics Inc Peroxisome Proliferator Activated Receptor Delta Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 T3D Therapeutics Inc Peroxisome Proliferator Activated Receptor Delta Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 T3D Therapeutics Inc Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Peroxisome Proliferator Activated Receptor Delta Industry Chain Analysis
12.2 Peroxisome Proliferator Activated Receptor Delta Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Peroxisome Proliferator Activated Receptor Delta Production Mode & Process
12.4 Peroxisome Proliferator Activated Receptor Delta Sales and Marketing
12.4.1 Peroxisome Proliferator Activated Receptor Delta Sales Channels
12.4.2 Peroxisome Proliferator Activated Receptor Delta Distributors
12.5 Peroxisome Proliferator Activated Receptor Delta Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Peroxisome Proliferator Activated Receptor Delta Industry Trends
13.2 Peroxisome Proliferator Activated Receptor Delta Market Drivers
13.3 Peroxisome Proliferator Activated Receptor Delta Market Challenges
13.4 Peroxisome Proliferator Activated Receptor Delta Market Restraints
14 Key Findings in The Global Peroxisome Proliferator Activated Receptor Delta Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Peroxisome Proliferator Activated Receptor Delta Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of MTB-2
Table 3. Major Manufacturers of HPP-593
Table 4. Major Manufacturers of CNX-013B2
Table 5. Major Manufacturers of CS-038
Table 6. Major Manufacturers of MA-0204
Table 7. Major Manufacturers of Others
Table 8. Global Peroxisome Proliferator Activated Receptor Delta Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 9. Global Peroxisome Proliferator Activated Receptor Delta Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 10. Global Peroxisome Proliferator Activated Receptor Delta Sales by Region (2017-2022) & (K Pcs)
Table 11. Global Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Region (2017-2022)
Table 12. Global Peroxisome Proliferator Activated Receptor Delta Sales by Region (2023-2028) & (K Pcs)
Table 13. Global Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Region (2023-2028)
Table 14. Global Peroxisome Proliferator Activated Receptor Delta Revenue by Region (2017-2022) & (US$ Million)
Table 15. Global Peroxisome Proliferator Activated Receptor Delta Revenue Market Share by Region (2017-2022)
Table 16. Global Peroxisome Proliferator Activated Receptor Delta Revenue by Region (2023-2028) & (US$ Million)
Table 17. Global Peroxisome Proliferator Activated Receptor Delta Revenue Market Share by Region (2023-2028)
Table 18. Global Peroxisome Proliferator Activated Receptor Delta Sales by Manufacturers (2017-2022) & (K Pcs)
Table 19. Global Peroxisome Proliferator Activated Receptor Delta Sales Share by Manufacturers (2017-2022)
Table 20. Global Peroxisome Proliferator Activated Receptor Delta Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 21. Global Peroxisome Proliferator Activated Receptor Delta Revenue Share by Manufacturers (2017-2022)
Table 22. Peroxisome Proliferator Activated Receptor Delta Price by Manufacturers (2017-2022) &(USD/Pcs)
Table 23. Global Peroxisome Proliferator Activated Receptor Delta Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Peroxisome Proliferator Activated Receptor Delta by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peroxisome Proliferator Activated Receptor Delta as of 2021)
Table 25. Peroxisome Proliferator Activated Receptor Delta Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Peroxisome Proliferator Activated Receptor Delta Product Offered
Table 27. Date of Manufacturers Enter into Peroxisome Proliferator Activated Receptor Delta Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Peroxisome Proliferator Activated Receptor Delta Sales by Type (2017-2022) & (K Pcs)
Table 30. Global Peroxisome Proliferator Activated Receptor Delta Sales by Type (2023-2028) & (K Pcs)
Table 31. Global Peroxisome Proliferator Activated Receptor Delta Sales Share by Type (2017-2022)
Table 32. Global Peroxisome Proliferator Activated Receptor Delta Sales Share by Type (2023-2028)
Table 33. Global Peroxisome Proliferator Activated Receptor Delta Revenue by Type (2017-2022) & (US$ Million)
Table 34. Global Peroxisome Proliferator Activated Receptor Delta Revenue by Type (2023-2028) & (US$ Million)
Table 35. Global Peroxisome Proliferator Activated Receptor Delta Revenue Share by Type (2017-2022)
Table 36. Global Peroxisome Proliferator Activated Receptor Delta Revenue Share by Type (2023-2028)
Table 37. Peroxisome Proliferator Activated Receptor Delta Price by Type (2017-2022) & (USD/Pcs)
Table 38. Global Peroxisome Proliferator Activated Receptor Delta Price Forecast by Type (2023-2028) & (USD/Pcs)
Table 39. Global Peroxisome Proliferator Activated Receptor Delta Sales by Application (2017-2022) & (K Pcs)
Table 40. Global Peroxisome Proliferator Activated Receptor Delta Sales by Application (2023-2028) & (K Pcs)
Table 41. Global Peroxisome Proliferator Activated Receptor Delta Sales Share by Application (2017-2022)
Table 42. Global Peroxisome Proliferator Activated Receptor Delta Sales Share by Application (2023-2028)
Table 43. Global Peroxisome Proliferator Activated Receptor Delta Revenue by Application (2017-2022) & (US$ Million)
Table 44. Global Peroxisome Proliferator Activated Receptor Delta Revenue by Application (2023-2028) & (US$ Million)
Table 45. Global Peroxisome Proliferator Activated Receptor Delta Revenue Share by Application (2017-2022)
Table 46. Global Peroxisome Proliferator Activated Receptor Delta Revenue Share by Application (2023-2028)
Table 47. Peroxisome Proliferator Activated Receptor Delta Price by Application (2017-2022) & (USD/Pcs)
Table 48. Global Peroxisome Proliferator Activated Receptor Delta Price Forecast by Application (2023-2028) & (USD/Pcs)
Table 49. North America Peroxisome Proliferator Activated Receptor Delta Sales by Type (2017-2022) & (K Pcs)
Table 50. North America Peroxisome Proliferator Activated Receptor Delta Sales by Type (2023-2028) & (K Pcs)
Table 51. North America Peroxisome Proliferator Activated Receptor Delta Revenue by Type (2017-2022) & (US$ Million)
Table 52. North America Peroxisome Proliferator Activated Receptor Delta Revenue by Type (2023-2028) & (US$ Million)
Table 53. North America Peroxisome Proliferator Activated Receptor Delta Sales by Application (2017-2022) & (K Pcs)
Table 54. North America Peroxisome Proliferator Activated Receptor Delta Sales by Application (2023-2028) & (K Pcs)
Table 55. North America Peroxisome Proliferator Activated Receptor Delta Revenue by Application (2017-2022) & (US$ Million)
Table 56. North America Peroxisome Proliferator Activated Receptor Delta Revenue by Application (2023-2028) & (US$ Million)
Table 57. North America Peroxisome Proliferator Activated Receptor Delta Sales by Country (2017-2022) & (K Pcs)
Table 58. North America Peroxisome Proliferator Activated Receptor Delta Sales by Country (2023-2028) & (K Pcs)
Table 59. North America Peroxisome Proliferator Activated Receptor Delta Revenue by Country (2017-2022) & (US$ Million)
Table 60. North America Peroxisome Proliferator Activated Receptor Delta Revenue by Country (2023-2028) & (US$ Million)
Table 61. Europe Peroxisome Proliferator Activated Receptor Delta Sales by Type (2017-2022) & (K Pcs)
Table 62. Europe Peroxisome Proliferator Activated Receptor Delta Sales by Type (2023-2028) & (K Pcs)
Table 63. Europe Peroxisome Proliferator Activated Receptor Delta Revenue by Type (2017-2022) & (US$ Million)
Table 64. Europe Peroxisome Proliferator Activated Receptor Delta Revenue by Type (2023-2028) & (US$ Million)
Table 65. Europe Peroxisome Proliferator Activated Receptor Delta Sales by Application (2017-2022) & (K Pcs)
Table 66. Europe Peroxisome Proliferator Activated Receptor Delta Sales by Application (2023-2028) & (K Pcs)
Table 67. Europe Peroxisome Proliferator Activated Receptor Delta Revenue by Application (2017-2022) & (US$ Million)
Table 68. Europe Peroxisome Proliferator Activated Receptor Delta Revenue by Application (2023-2028) & (US$ Million)
Table 69. Europe Peroxisome Proliferator Activated Receptor Delta Sales by Country (2017-2022) & (K Pcs)
Table 70. Europe Peroxisome Proliferator Activated Receptor Delta Sales by Country (2023-2028) & (K Pcs)
Table 71. Europe Peroxisome Proliferator Activated Receptor Delta Revenue by Country (2017-2022) & (US$ Million)
Table 72. Europe Peroxisome Proliferator Activated Receptor Delta Revenue by Country (2023-2028) & (US$ Million)
Table 73. Asia Pacific Peroxisome Proliferator Activated Receptor Delta Sales by Type (2017-2022) & (K Pcs)
Table 74. Asia Pacific Peroxisome Proliferator Activated Receptor Delta Sales by Type (2023-2028) & (K Pcs)
Table 75. Asia Pacific Peroxisome Proliferator Activated Receptor Delta Revenue by Type (2017-2022) & (US$ Million)
Table 76. Asia Pacific Peroxisome Proliferator Activated Receptor Delta Revenue by Type (2023-2028) & (US$ Million)
Table 77. Asia Pacific Peroxisome Proliferator Activated Receptor Delta Sales by Application (2017-2022) & (K Pcs)
Table 78. Asia Pacific Peroxisome Proliferator Activated Receptor Delta Sales by Application (2023-2028) & (K Pcs)
Table 79. Asia Pacific Peroxisome Proliferator Activated Receptor Delta Revenue by Application (2017-2022) & (US$ Million)
Table 80. Asia Pacific Peroxisome Proliferator Activated Receptor Delta Revenue by Application (2023-2028) & (US$ Million)
Table 81. Asia Pacific Peroxisome Proliferator Activated Receptor Delta Sales by Region (2017-2022) & (K Pcs)
Table 82. Asia Pacific Peroxisome Proliferator Activated Receptor Delta Sales by Region (2023-2028) & (K Pcs)
Table 83. Asia Pacific Peroxisome Proliferator Activated Receptor Delta Revenue by Region (2017-2022) & (US$ Million)
Table 84. Asia Pacific Peroxisome Proliferator Activated Receptor Delta Revenue by Region (2023-2028) & (US$ Million)
Table 85. Latin America Peroxisome Proliferator Activated Receptor Delta Sales by Type (2017-2022) & (K Pcs)
Table 86. Latin America Peroxisome Proliferator Activated Receptor Delta Sales by Type (2023-2028) & (K Pcs)
Table 87. Latin America Peroxisome Proliferator Activated Receptor Delta Revenue by Type (2017-2022) & (US$ Million)
Table 88. Latin America Peroxisome Proliferator Activated Receptor Delta Revenue by Type (2023-2028) & (US$ Million)
Table 89. Latin America Peroxisome Proliferator Activated Receptor Delta Sales by Application (2017-2022) & (K Pcs)
Table 90. Latin America Peroxisome Proliferator Activated Receptor Delta Sales by Application (2023-2028) & (K Pcs)
Table 91. Latin America Peroxisome Proliferator Activated Receptor Delta Revenue by Application (2017-2022) & (US$ Million)
Table 92. Latin America Peroxisome Proliferator Activated Receptor Delta Revenue by Application (2023-2028) & (US$ Million)
Table 93. Latin America Peroxisome Proliferator Activated Receptor Delta Sales by Country (2017-2022) & (K Pcs)
Table 94. Latin America Peroxisome Proliferator Activated Receptor Delta Sales by Country (2023-2028) & (K Pcs)
Table 95. Latin America Peroxisome Proliferator Activated Receptor Delta Revenue by Country (2017-2022) & (US$ Million)
Table 96. Latin America Peroxisome Proliferator Activated Receptor Delta Revenue by Country (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Peroxisome Proliferator Activated Receptor Delta Sales by Type (2017-2022) & (K Pcs)
Table 98. Middle East and Africa Peroxisome Proliferator Activated Receptor Delta Sales by Type (2023-2028) & (K Pcs)
Table 99. Middle East and Africa Peroxisome Proliferator Activated Receptor Delta Revenue by Type (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Peroxisome Proliferator Activated Receptor Delta Revenue by Type (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Peroxisome Proliferator Activated Receptor Delta Sales by Application (2017-2022) & (K Pcs)
Table 102. Middle East and Africa Peroxisome Proliferator Activated Receptor Delta Sales by Application (2023-2028) & (K Pcs)
Table 103. Middle East and Africa Peroxisome Proliferator Activated Receptor Delta Revenue by Application (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Peroxisome Proliferator Activated Receptor Delta Revenue by Application (2023-2028) & (US$ Million)
Table 105. Middle East and Africa Peroxisome Proliferator Activated Receptor Delta Sales by Country (2017-2022) & (K Pcs)
Table 106. Middle East and Africa Peroxisome Proliferator Activated Receptor Delta Sales by Country (2023-2028) & (K Pcs)
Table 107. Middle East and Africa Peroxisome Proliferator Activated Receptor Delta Revenue by Country (2017-2022) & (US$ Million)
Table 108. Middle East and Africa Peroxisome Proliferator Activated Receptor Delta Revenue by Country (2023-2028) & (US$ Million)
Table 109. Chipscreen Biosciences Ltd Corporation Information
Table 110. Chipscreen Biosciences Ltd Description and Major Businesses
Table 111. Chipscreen Biosciences Ltd Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 112. Chipscreen Biosciences Ltd Peroxisome Proliferator Activated Receptor Delta Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. Chipscreen Biosciences Ltd Recent Developments
Table 114. Connexios Life Sciences Pvt Ltd Corporation Information
Table 115. Connexios Life Sciences Pvt Ltd Description and Major Businesses
Table 116. Connexios Life Sciences Pvt Ltd Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 117. Connexios Life Sciences Pvt Ltd Peroxisome Proliferator Activated Receptor Delta Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. Connexios Life Sciences Pvt Ltd Recent Developments
Table 119. CymaBay Therapeutics Inc Corporation Information
Table 120. CymaBay Therapeutics Inc Description and Major Businesses
Table 121. CymaBay Therapeutics Inc Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 122. CymaBay Therapeutics Inc Peroxisome Proliferator Activated Receptor Delta Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. CymaBay Therapeutics Inc Recent Developments
Table 124. Genfit SA Corporation Information
Table 125. Genfit SA Description and Major Businesses
Table 126. Genfit SA Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 127. Genfit SA Peroxisome Proliferator Activated Receptor Delta Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Genfit SA Recent Developments
Table 129. Inventiva Corporation Information
Table 130. Inventiva Description and Major Businesses
Table 131. Inventiva Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 132. Inventiva Peroxisome Proliferator Activated Receptor Delta Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. Inventiva Recent Developments
Table 134. Mitobridge Inc Corporation Information
Table 135. Mitobridge Inc Description and Major Businesses
Table 136. Mitobridge Inc Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 137. Mitobridge Inc Peroxisome Proliferator Activated Receptor Delta Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. Mitobridge Inc Recent Developments
Table 139. Nippon Chemiphar Co Ltd Corporation Information
Table 140. Nippon Chemiphar Co Ltd Description and Major Businesses
Table 141. Nippon Chemiphar Co Ltd Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 142. Nippon Chemiphar Co Ltd Peroxisome Proliferator Activated Receptor Delta Product Model Numbers, Pictures, Descriptions and Specifications
Table 143. Nippon Chemiphar Co Ltd Recent Developments
Table 144. Senju Pharmaceutical Co Ltd Corporation Information
Table 145. Senju Pharmaceutical Co Ltd Description and Major Businesses
Table 146. Senju Pharmaceutical Co Ltd Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 147. Senju Pharmaceutical Co Ltd Peroxisome Proliferator Activated Receptor Delta Product Model Numbers, Pictures, Descriptions and Specifications
Table 148. Senju Pharmaceutical Co Ltd Recent Developments
Table 149. T3D Therapeutics Inc Corporation Information
Table 150. T3D Therapeutics Inc Description and Major Businesses
Table 151. T3D Therapeutics Inc Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 152. T3D Therapeutics Inc Peroxisome Proliferator Activated Receptor Delta Product Model Numbers, Pictures, Descriptions and Specifications
Table 153. T3D Therapeutics Inc Recent Developments
Table 154. Key Raw Materials Lists
Table 155. Raw Materials Key Suppliers Lists
Table 156. Peroxisome Proliferator Activated Receptor Delta Distributors List
Table 157. Peroxisome Proliferator Activated Receptor Delta Customers List
Table 158. Peroxisome Proliferator Activated Receptor Delta Market Trends
Table 159. Peroxisome Proliferator Activated Receptor Delta Market Drivers
Table 160. Peroxisome Proliferator Activated Receptor Delta Market Challenges
Table 161. Peroxisome Proliferator Activated Receptor Delta Market Restraints
Table 162. Research Programs/Design for This Report
Table 163. Key Data Information from Secondary Sources
Table 164. Key Data Information from Primary Sources
List of Figures
Figure 1. Peroxisome Proliferator Activated Receptor Delta Product Picture
Figure 3. Global Peroxisome Proliferator Activated Receptor Delta Market Share by Type in 2021 & 2028
Figure 3. MTB-2 Product Picture
Figure 4. HPP-593 Product Picture
Figure 5. CNX-013B2 Product Picture
Figure 6. CS-038 Product Picture
Figure 7. MA-0204 Product Picture
Figure 8. Others Product Picture
Figure 9. Global Peroxisome Proliferator Activated Receptor Delta Market Share by Application in 2021 & 2028
Figure 10. Bone Disorders
Figure 11. Colitis
Figure 12. Obesity
Figure 13. Osteoporosis
Figure 14. Others
Figure 15. Peroxisome Proliferator Activated Receptor Delta Report Years Considered
Figure 16. Global Peroxisome Proliferator Activated Receptor Delta Sales 2017-2028 (K Pcs)
Figure 17. Global Peroxisome Proliferator Activated Receptor Delta Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 18. Global Peroxisome Proliferator Activated Receptor Delta Revenue 2017-2028 (US$ Million)
Figure 19. Global Peroxisome Proliferator Activated Receptor Delta Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 20. Global Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Region (2017-2022)
Figure 21. Global Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Region (2023-2028)
Figure 22. North America Peroxisome Proliferator Activated Receptor Delta Sales YoY (2017-2028) & (K Pcs)
Figure 23. North America Peroxisome Proliferator Activated Receptor Delta Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Europe Peroxisome Proliferator Activated Receptor Delta Sales YoY (2017-2028) & (K Pcs)
Figure 25. Europe Peroxisome Proliferator Activated Receptor Delta Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Asia-Pacific Peroxisome Proliferator Activated Receptor Delta Sales YoY (2017-2028) & (K Pcs)
Figure 27. Asia-Pacific Peroxisome Proliferator Activated Receptor Delta Revenue YoY (2017-2028) & (US$ Million)
Figure 28. Latin America Peroxisome Proliferator Activated Receptor Delta Sales YoY (2017-2028) & (K Pcs)
Figure 29. Latin America Peroxisome Proliferator Activated Receptor Delta Revenue YoY (2017-2028) & (US$ Million)
Figure 30. Middle East & Africa Peroxisome Proliferator Activated Receptor Delta Sales YoY (2017-2028) & (K Pcs)
Figure 31. Middle East & Africa Peroxisome Proliferator Activated Receptor Delta Revenue YoY (2017-2028) & (US$ Million)
Figure 32. The Peroxisome Proliferator Activated Receptor Delta Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 33. The Top 5 and 10 Largest Manufacturers of Peroxisome Proliferator Activated Receptor Delta in the World: Market Share by Peroxisome Proliferator Activated Receptor Delta Revenue in 2021
Figure 34. Global Peroxisome Proliferator Activated Receptor Delta Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 35. Global Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Type (2017-2028)
Figure 36. Global Peroxisome Proliferator Activated Receptor Delta Revenue Market Share by Type (2017-2028)
Figure 37. Global Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Application (2017-2028)
Figure 38. Global Peroxisome Proliferator Activated Receptor Delta Revenue Market Share by Application (2017-2028)
Figure 39. North America Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Type (2017-2028)
Figure 40. North America Peroxisome Proliferator Activated Receptor Delta Revenue Market Share by Type (2017-2028)
Figure 41. North America Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Application (2017-2028)
Figure 42. North America Peroxisome Proliferator Activated Receptor Delta Revenue Market Share by Application (2017-2028)
Figure 43. North America Peroxisome Proliferator Activated Receptor Delta Sales Share by Country (2017-2028)
Figure 44. North America Peroxisome Proliferator Activated Receptor Delta Revenue Share by Country (2017-2028)
Figure 45. U.S. Peroxisome Proliferator Activated Receptor Delta Revenue (2017-2028) & (US$ Million)
Figure 46. Canada Peroxisome Proliferator Activated Receptor Delta Revenue (2017-2028) & (US$ Million)
Figure 47. Europe Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Type (2017-2028)
Figure 48. Europe Peroxisome Proliferator Activated Receptor Delta Revenue Market Share by Type (2017-2028)
Figure 49. Europe Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Application (2017-2028)
Figure 50. Europe Peroxisome Proliferator Activated Receptor Delta Revenue Market Share by Application (2017-2028)
Figure 51. Europe Peroxisome Proliferator Activated Receptor Delta Sales Share by Country (2017-2028)
Figure 52. Europe Peroxisome Proliferator Activated Receptor Delta Revenue Share by Country (2017-2028)
Figure 53. Germany Peroxisome Proliferator Activated Receptor Delta Revenue (2017-2028) & (US$ Million)
Figure 54. France Peroxisome Proliferator Activated Receptor Delta Revenue (2017-2028) & (US$ Million)
Figure 55. U.K. Peroxisome Proliferator Activated Receptor Delta Revenue (2017-2028) & (US$ Million)
Figure 56. Italy Peroxisome Proliferator Activated Receptor Delta Revenue (2017-2028) & (US$ Million)
Figure 57. Russia Peroxisome Proliferator Activated Receptor Delta Revenue (2017-2028) & (US$ Million)
Figure 58. Asia Pacific Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Type (2017-2028)
Figure 59. Asia Pacific Peroxisome Proliferator Activated Receptor Delta Revenue Market Share by Type (2017-2028)
Figure 60. Asia Pacific Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Application (2017-2028)
Figure 61. Asia Pacific Peroxisome Proliferator Activated Receptor Delta Revenue Market Share by Application (2017-2028)
Figure 62. Asia Pacific Peroxisome Proliferator Activated Receptor Delta Sales Share by Region (2017-2028)
Figure 63. Asia Pacific Peroxisome Proliferator Activated Receptor Delta Revenue Share by Region (2017-2028)
Figure 64. China Peroxisome Proliferator Activated Receptor Delta Revenue (2017-2028) & (US$ Million)
Figure 65. Japan Peroxisome Proliferator Activated Receptor Delta Revenue (2017-2028) & (US$ Million)
Figure 66. South Korea Peroxisome Proliferator Activated Receptor Delta Revenue (2017-2028) & (US$ Million)
Figure 67. India Peroxisome Proliferator Activated Receptor Delta Revenue (2017-2028) & (US$ Million)
Figure 68. Australia Peroxisome Proliferator Activated Receptor Delta Revenue (2017-2028) & (US$ Million)
Figure 69. Taiwan Peroxisome Proliferator Activated Receptor Delta Revenue (2017-2028) & (US$ Million)
Figure 70. Indonesia Peroxisome Proliferator Activated Receptor Delta Revenue (2017-2028) & (US$ Million)
Figure 71. Thailand Peroxisome Proliferator Activated Receptor Delta Revenue (2017-2028) & (US$ Million)
Figure 72. Malaysia Peroxisome Proliferator Activated Receptor Delta Revenue (2017-2028) & (US$ Million)
Figure 73. Philippines Peroxisome Proliferator Activated Receptor Delta Revenue (2017-2028) & (US$ Million)
Figure 74. Latin America Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Type (2017-2028)
Figure 75. Latin America Peroxisome Proliferator Activated Receptor Delta Revenue Market Share by Type (2017-2028)
Figure 76. Latin America Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Application (2017-2028)
Figure 77. Latin America Peroxisome Proliferator Activated Receptor Delta Revenue Market Share by Application (2017-2028)
Figure 78. Latin America Peroxisome Proliferator Activated Receptor Delta Sales Share by Country (2017-2028)
Figure 79. Latin America Peroxisome Proliferator Activated Receptor Delta Revenue Share by Country (2017-2028)
Figure 80. Mexico Peroxisome Proliferator Activated Receptor Delta Revenue (2017-2028) & (US$ Million)
Figure 81. Brazil Peroxisome Proliferator Activated Receptor Delta Revenue (2017-2028) & (US$ Million)
Figure 82. Argentina Peroxisome Proliferator Activated Receptor Delta Revenue (2017-2028) & (US$ Million)
Figure 83. Middle East and Africa Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Type (2017-2028)
Figure 84. Middle East and Africa Peroxisome Proliferator Activated Receptor Delta Revenue Market Share by Type (2017-2028)
Figure 85. Middle East and Africa Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Application (2017-2028)
Figure 86. Middle East and Africa Peroxisome Proliferator Activated Receptor Delta Revenue Market Share by Application (2017-2028)
Figure 87. Middle East and Africa Peroxisome Proliferator Activated Receptor Delta Sales Share by Country (2017-2028)
Figure 88. Middle East and Africa Peroxisome Proliferator Activated Receptor Delta Revenue Share by Country (2017-2028)
Figure 89. Turkey Peroxisome Proliferator Activated Receptor Delta Revenue (2017-2028) & (US$ Million)
Figure 90. Saudi Arabia Peroxisome Proliferator Activated Receptor Delta Revenue (2017-2028) & (US$ Million)
Figure 91. U.A.E Peroxisome Proliferator Activated Receptor Delta Revenue (2017-2028) & (US$ Million)
Figure 92. Peroxisome Proliferator Activated Receptor Delta Value Chain
Figure 93. Peroxisome Proliferator Activated Receptor Delta Production Process
Figure 94. Channels of Distribution
Figure 95. Distributors Profiles
Figure 96. Bottom-up and Top-down Approaches for This Report
Figure 97. Data Triangulation
Figure 98. Key Executives Interviewed
Industry Market Size
